Substance P in the nucleus of the solitary tract augments bronchopulmonary C fiber reflex output

Tatsushi Mutoh1,2, Ann C. Bonham2, Jesse P. Joad1
1Department of Pediatrics, University of California, Davis, Sacramento, California 95616
2Departments of Internal Medicine and Pharmacology and

Tóm tắt

Bronchopulmonary C fibers defend the lungs against injury from inhaled agents by a central nervous system reflex consisting of apnea, cough, bronchoconstriction, hypotension, and bradycardia. Glutamate is the putative neurotransmitter at the first central synapses in the nucleus of the solitary tract (NTS), but substance P, also released in the NTS, may modulate the transmission. To test the hypothesis that substance P in the NTS augments bronchopulmonary C fiber input and hence reflex output, we stimulated the C fibers with left atrial capsaicin (LA CAP) injections and compared the changes in phrenic nerve discharge, tracheal pressure (TP), arterial blood pressure (ABP), and heart rate (HR) in guinea pigs before and after substance P injections (200 μM, 25 nl) in the NTS. Substance P significantly augmented LA CAP-evoked increases in expiratory time by 10-fold and increases in TP and decreases in ABP and HR by threefold, effects prevented by neurokinin-1 (NK1) receptor antagonism. Thus substance P acting at NTS NK1 receptors can exaggerate bronchopulmonary C fiber reflex output. Because substance P synthesis in vagal airway C fibers may be enhanced in pathological conditions such as allergic asthma, the findings may help explain some of the associated respiratory symptoms including cough and bronchoconstriction.

Từ khóa


Tài liệu tham khảo

10.1152/ajpheart.1990.259.4.H1307

10.1152/jn.1997.77.5.2539

10.1111/j.1476-5381.1993.tb13466.x

10.1002/(SICI)1096-9861(19981214)402:2<181::AID-CNE4>3.0.CO;2-B

10.1113/jphysiol.1993.sp019660

10.1113/jphysiol.1991.sp018740

10.1113/jphysiol.1990.sp018171

10.1016/0006-8993(80)91293-7

Buck SH, 1986, Pharmacol Rev, 38, 179

10.1016/S0165-1838(98)00018-6

10.1016/0143-4179(85)90141-6

10.1016/0167-0115(90)90083-9

10.1007/BFb0027715

10.1038/264451a0

10.1152/jappl.1993.74.5.2345

10.1016/S0304-3940(99)00920-9

10.1002/cne.901780108

10.1097/00001756-199705060-00031

10.1097/00001756-199904060-00020

Feldman PD., 1995, J Pharmacol Exp Ther, 273, 617

10.1172/JCI119039

10.1016/0006-8993(95)00728-9

10.1016/0006-8993(80)90633-2

10.1007/BF00504526

10.1016/0024-3205(81)90188-0

10.1016/0196-9781(80)90027-3

10.1016/0306-4522(84)90148-9

10.1016/0306-4522(85)90149-6

10.1002/cne.901930216

10.1016/0304-3940(89)90431-X

10.1113/jphysiol.1991.sp018506

10.1111/j.1440-1681.1995.tb01953.x

10.1152/jappl.1989.66.5.2032

10.1016/0006-8993(87)90938-3

10.1139/y95-125

10.1016/S0006-8993(97)01335-8

10.1038/sj.bjp.0701482

10.1038/sj.bjp.0702522

Mazzone SB, 1997, J Pharmacol Exp Ther, 282, 1547

10.1111/j.1471-4159.1989.tb09247.x

10.1016/0006-8993(84)90502-X

10.1152/jappl.1999.87.2.757

10.1111/j.1469-7793.2000.00223.x

10.1046/j.1460-9568.1998.00238.x

10.1152/jappl.1992.73.6.2305

10.1113/expphysiol.1995.sp003839

10.1164/ajrccm/137.6.1330

10.1016/0014-2999(92)90057-B

10.1126/science.1703323

10.1016/0006-8993(91)91483-H

10.1016/0306-4522(94)90110-4

10.1016/0006-8993(93)90424-L

10.1113/jphysiol.1996.sp021726

10.1016/S0196-9781(97)00139-3